“In close consultation with the South African Health Products Authority (Sahpra), Bayer has initiated a Class II, Type A recall for the Yaz Plus tablets batch identified as WEW96J, with an expiry date of March 2026,” medical director for Bayer’s pharmaceuticals division Dr Naren Jairam said on Thursday.
“This measure was taken following a discovery of a packaging mix-up in a limited number of packs which could potentially compromise the product’s contraceptive efficacy.
